TRAM1

Translocating chain-associated membrane protein 1 · Q15629 · TRAM1 on Sugi Atlas →

0 patent compounds predicted against TRAM1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TRAM1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Glycerol-Phenylbutyrate Treatment in Children With MCT Mutation (Allan-Herndon- Dudley Syndrome) PHASE2/PHASE3UNKNOWN
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant PHASE1/PHASE2RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis PHASE2UNKNOWN
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
MCS110 With BRAF/MEK Inhibition in Patients With Melanoma PHASE1/PHASE2COMPLETED
Biologic Correlative Taxotere/AC PHASE2COMPLETED
TEIPP Immunotherapy in Patients With NSCLC PHASE1/PHASE2COMPLETED
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) PHASE2COMPLETED
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma PHASE1ACTIVE_NOT_RECRUITING
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients PHASE1UNKNOWN
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence nanNOT_YET_RECRUITING
Immune Cell Response to Stimuli nanRECRUITING
Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression nanNOT_YET_RECRUITING
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
Predicting Pancreatic Necrosis Using mitDNA nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Evaluation of CEMIP in Pancreatic Cancer nanUNKNOWN
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors nanUNKNOWN
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma? nanRECRUITING
Mitoquines in COPD nanUNKNOWN
Renal Transporters After Renal Transplantation nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a TRAM1 binder may also engage these)

ProteinNameSimilarity
Q01685 1.000 Q01685 →
Q5R7Z3 1.000 Q5R7Z3 →
Q9GKZ4 1.000 Q9GKZ4 →
Q91V04 1.000 Q91V04 →
Q6DED0 1.000 Q6DED0 →
Q5XI41 1.000 Q5XI41 →
Q924Z5 0.984 Q924Z5 →
Q15035 0.984 Q15035 →
Q9LDF2 0.964 Q9LDF2 →
Q6EUN0 0.961 Q6EUN0 →
A8DZH4 0.959 A8DZH4 →
Q58E26 0.959 Q58E26 →
Q5F3F5 0.959 Q5F3F5 →
Q8C561 0.959 Q8C561 →
Q8N609 0.958 Q8N609 →
Q6DD44 0.958 Q6DD44 →
Q5ZM57 0.958 Q5ZM57 →
Q6P4P2 0.958 Q6P4P2 →
Q5VWC8 0.958 Q5VWC8 →
Q68DH5 0.958 Q68DH5 →
Q28CY9 0.957 Q28CY9 →
Q9QZ71 0.956 Q9QZ71 →
A7YY55 0.956 A7YY55 →
Q6IQC7 0.956 Q6IQC7 →
Q3SYY9 0.956 Q3SYY9 →
Q6DFS0 0.955 Q6DFS0 →
Q58DA4 0.955 Q58DA4 →
Q5RF53 0.955 Q5RF53 →
D3ZEH5 0.954 D3ZEH5 →
Q7SY06 0.954 Q7SY06 →